SM
Sabby Management Portfolio holdings
AUM
$13M
1-Year Return
26.95%
This Quarter Return
-1.2%
1 Year Return
-26.95%
3 Year Return
-56.43%
5 Year Return
-61.92%
10 Year Return
-71.17%
AUM
$857K
AUM Growth
-$338M
(-100%)
Cap. Flow
-$216M
Cap. Flow
% of AUM
-25,215.09%
Top 10 Holdings %
Top 10 Hldgs %
83.46%
Holding
201
New
46
Increased
31
Reduced
25
Closed
40
Top Buys
| 1 |
Acadia Healthcare
ACHC
|
$16.4K |
| 2 |
GEVA
SYNAGEVA BIOPHARMA CORP COM STK (DE)
GEVA
|
$9.99K |
| 3 |
AGN
Allergan plc
AGN
|
$6.96K |
| 4 |
ProQR Therapeutics
PRQR
|
$6.55K |
| 5 |
Larimar Therapeutics
LRMR
|
$6.44K |
Top Sells
| 1 |
Weyerhaeuser
WY
|
$64.6M |
| 2 |
Teva Pharmaceuticals
TEVA
|
$53.1M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
$13.6M |
| 4 |
Acadia Pharmaceuticals
ACAD
|
$13.3M |
| 5 |
Opko Health
OPK
|
$10.6M |
Sector Composition
| 1 | Healthcare | 19.58% |
| 2 | Energy | 1.42% |
| 3 | Consumer Discretionary | 1.09% |
| 4 | Industrials | 0.47% |
| 5 | Financials | 0.23% |
